Aspergillosis: Epidemiology, Diagnosis, and Treatment

Area of Science:

• Medical Mycology
• Infectious Diseases

Background:

• Aspergillus species cause a wide range of diseases, from allergies to life-threatening invasive infections.
• Invasive aspergillosis is a significant cause of death in immunocompromised patients.
• Evolving risk factors include novel immunomodulatory agents, influenza, and COVID-19 infections.

Purpose of the Study:

• To review the current understanding of Aspergillus-related diseases.
• To highlight challenges in diagnosis and emerging antifungal resistance.
• To discuss current and alternative treatment strategies.

Main Methods:

• Literature review of recent studies on Aspergillus infections.
• Analysis of evolving risk factors and diagnostic approaches.
• Evaluation of current and emerging antifungal therapies.

Main Results:

• Invasive aspergillosis remains a critical threat in immunocompromised populations.
• Non-culture-based diagnostic methods are available but diagnosis remains challenging.
• Antifungal resistance is an increasing problem, necessitating alternative treatment strategies.
• Newer azoles like isavuconazole and posaconazole offer alternatives to voriconazole with potentially reduced toxicity.

Conclusions:

• Aspergillus infections require vigilant monitoring due to evolving risks and resistance.
• Optimizing diagnostic tools and treatment regimens is crucial for improving patient outcomes.
• Combination therapy may be necessary for severe cases and profound immunosuppression.